ORIC Pharmaceuticals Inc (NASDAQ: ORIC) is 11.09% higher on its value in year-to-date trading and has touched a low of $5.27 and a high of $16.65 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ORIC stock was last observed hovering at around $10.99 in the last trading session, with the day’s loss setting it -0.77%.
Currently trading at $10.22, the stock is 25.94% and 19.29% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.95 million and changing -7.01% at the moment leaves the stock 10.18% off its SMA200. ORIC registered 24.18% gain for a year compared to 6-month loss of 22.54%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 36.45% gain in the last 1 month and extending the period to 3 months gives it a 8.15%, and is 9.54% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.35% over the week and 8.19% over the month.
ORIC Pharmaceuticals Inc (ORIC) has around 100 employees, a market worth around $689.03M and $0.00M in sales. Distance from 52-week low is 93.93% and -38.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.96%).
The EPS is expected to grow by 12.20% this year
The shares outstanding are 54.87M, and float is at 43.31M with Short Float at 27.02%.
ORIC Pharmaceuticals Inc (ORIC) Insider Activity
The most recent transaction is an insider sale by Chacko Jacob, the company’s PRESIDENT AND CEO. SEC filings show that Chacko Jacob sold 40,000 shares of the company’s common stock on Mar 06 ’24 at a price of $16.21 per share for a total of $0.65 million. Following the sale, the insider now owns 0.73 million shares.
ORIC Pharmaceuticals Inc disclosed in a document filed with the SEC on Feb 07 ’24 that Chacko Jacob (PRESIDENT AND CEO) sold a total of 26,042 shares of the company’s common stock. The trade occurred on Feb 07 ’24 and was made at $12.29 per share for $0.32 million. Following the transaction, the insider now directly holds 0.77 million shares of the ORIC stock.
Still, SEC filings show that on Feb 06 ’24, Chacko Jacob (PRESIDENT AND CEO) disposed off 13,958 shares at an average price of $12.12 for $0.17 million. The insider now directly holds 794,586 shares of ORIC Pharmaceuticals Inc (ORIC).
